Skip to content

A field-terminal readout on the BPC-157 + TB-500 'Wolverine' blend — the two-peptide repair literature, the missing combination data, and exactly where compounded access stands, logged like console telemetry.

04 — amounts used in animals

BPC-157 TB-500 dosage hasn't been established for your care

Is there an amount tested for your care? No; the animal amounts describe named studies, and you can't use them to set a human treatment plan.

BPC-157 and TB-500 animal amounts don't establish your care

Is there a tested BPC-157 TB-500 dosage for you? No; animal amounts don't establish a safe human amount [9].

BPC-157 studies often set amounts by the animal's body weight. Those numbers belong to research, rather than your treatment.

Rats with cut Achilles tendons received 10 micrograms or 10 nanograms for each kilogram of rat weight [1]. Both units measure tiny amounts.

A microgram measures a millionth part of a gram. A nanogram is the weight of one billionth of a gram.

BPC-157 rat stomach-ulcer studies used roughly 400-800 nanograms for each kilogram of rat weight [9]. You can't use that range as your own amount.

TB-500 claims also borrow whole Thymosin Beta-4 animal research. You won't find matching amounts or timing across the injuries.

Rat stroke studies tested 2-18 milligrams for each kilogram of rat weight. The best result was estimated near 3.75 milligrams per kilogram.

At 18 milligrams per kilogram, no benefit was found in rats [4]. A larger amount didn't necessarily work better.

In mice with muscle disease, researchers used 150 micrograms, twice weekly over six months [4]. Those amounts and times aren't established care for you.

Research labels may pair BPC-157 and TB-500 in fixed mixtures. A bottle may claim 10 mg plus 10 mg, or 20 mg total.

Those milligrams describe intended powder amounts [3][9]. Those labels can't establish your blend amount for your care.

Shots and swallowed products still lack blend trials

Researchers gave the separate substances in several ways. Your safe use of the blend hasn't been established.

Animal repair work often involved belly injections.

A “wolverine injection” claim doesn't establish a tested human treatment. Rodents in many healing studies received shots into the belly [9].

People discussing their own use describe muscle and under-skin shots. Those accounts aren't results from controlled human healing studies.

Phase 1 studies gave people whole Thymosin Beta-4 into a vein. These were early checks for safety, rather than blend healing trials.

An early BPC-157 safety study also used a vein [9]. Other tests applied substances to the skin or into an injury.

The swallowed pair hasn't had a fair healing test.

BPC-157 resisted breakdown in stomach conditions during research [9]. That finding drew interest in swallowing, but doesn't prove lasting benefit.

The “bpc 157 tb 500 oral” claim concerns both substances. You don't know how much of the swallowed mixture reaches blood.

Swallowed BPC-157 plus TB-500 lacks an established test of that question [9]. Most healing research gave the parts by other means.

You can't count stomach resistance as proof for the pair. Your question about swallowed treatment still needs human studies.

Research timing can't tell you when to take the mix

You don't have tested timing for the blend. The separate animal findings can't set your treatment schedule.

BPC-157 and TB-500 breakdown times remain unsettled in people.

Researchers haven't established breakdown at research amounts in people. You don't have that answer for the mixture, either.

BPC-157 fell to half its blood amount in under 30 minutes in rats and dogs [9]. Your body may handle the substance differently.

A breakdown time doesn't tell you how long healing effects last. People receiving more whole Thymosin Beta-4 into a vein had higher blood levels.

The short TB-500 piece lacks an established breakdown time [9]. You can't borrow the whole protein's result for the short protein part.

BPC-157 / TB-500 powder marked 10mg isn't a home mixing plan.

Research powders are frozen, then dried by removing the water. The lab adds clean water and keeps the mixture chilled [9].

Some water contains an ingredient that slows germ growth. That account of lab work isn't home preparation guidance.

A bottle may list 10 mg plus 10 mg [3]. Those milligrams give claimed amounts, rather than proof of correct contents.

You can't be sure of either substance's true amount or cleanliness. Unregulated research powder doesn't come with tested human mixing instructions.

BPC-157 and TB-500 shot timing is still unproved.

You don't have a proven shot schedule for this mix. Different animal injuries were tested with different timing.

Mice got Thymosin Beta-4 twice weekly for six months, 150 micrograms each time [4]. Those times describe the mice's study, rather than your care.

Accounts of people's own use don't establish safe timing. Only a fair human comparison could check that question [9].

BPC-157 and TB-500 starting and stopping plans remain untested.

Larger starting amounts still lack fair trials in people. You don't have established times for stopping or restarting.

In rat stroke work, Thymosin Beta-4 at 18 milligrams for each kilogram of rat weight gave no benefit [4]. More didn't automatically help.

Other animals and ways of giving substances used different times [9]. Your treatment can't be set by putting those schedules together.